Related Experiment Videos
[Comparative effectiveness of current pathogenetic methods of treating neurodermatitis]
Vestnik Dermatologii I Venerologii
|January 1, 1989
Summary
This study found that adrenoblockers, specific drug combinations, and adrenal area wave exposure effectively treat disseminated neurodermatitis. Corticosteroids are reserved for severe cases, with alternate-day dosing to minimize side effects.
Area of Science:
- Dermatology
- Pharmacology
- Pathophysiology
Background:
- Disseminated neurodermatitis presents challenges in treatment.
- Autonomic nervous system disorders are implicated in neurodermatitis pathogenesis.
- Atopic and non-atopic forms require tailored therapeutic approaches.
Purpose of the Study:
- To evaluate current pathogenetic treatment methods for disseminated neurodermatitis.
- To assess the efficacy of various therapeutic agents and modalities.
- To identify optimal treatment strategies for different neurodermatitis forms.
Main Methods:
- Comparative analysis of pathogenetic treatments in 258 patients.
- Clinical and laboratory assessments of treatment outcomes.
- Inclusion of adrenoblockers (pyrroxan, butyroxan), drug combinations (glycyrrham, voltaren), decimetric wave therapy, and an antibradykinin drug (parmidine).
Main Results:
- Adrenoblockers, pyrroxan and butyroxan, showed efficacy in patients with autonomic nervous system disorders.
- Combinations of glycyrrham and voltaren, along with decimetric wave exposure, were effective.
- Parmidine (2.0 g daily) demonstrated therapeutic benefits.
- Alternate-day corticosteroid administration proved effective for severe cases, reducing total drug dosage.
Conclusions:
- Multiple pathogenetic treatment modalities show promise for disseminated neurodermatitis.
- Targeting autonomic nervous system dysfunction is crucial.
- Sparing and physiological corticosteroid regimens are recommended for severe, refractory cases.